Endometrial microbiota alteration in female patients with endometrial polyps based on 16S rRNA gene sequencing analysis
Frontiers in Cellular and Infection Microbiology · 2024
DOI: 10.3389/fcimb.2024.1351329 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2024. Verfasst von Yu Zhao und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ambulatory Surgery, Women's Hospital School of Medicine Zhejiang University, Hangzhou, China. Hauptthemen laut MEDLINE: RNA, Ribosomal, 16S, Endometrium, Microbiota, Polyps. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
The potential role of the endometrial microbiota in the pathogenesis of endometrial polyps (EPs) warrants further investigation, given the current landscape of limited and inconclusive research findings. We aimed to explore the microecological characteristics of the uterine cavity in patients with EPs and investigate the potential of endometrial microbiota species as novel biomarkers for identifying EPs.
Methods
Endometrial samples were collected from 225 patients who underwent hysteroscopies, of whom 167 had EPs, whereas 58 had non- hyperproliferative endometrium status. The endometrial microbiota was assessed using 16S rRNA gene sequencing. We characterized the endometrial microbiota and identified microbial biomarkers for predicting EPs.
Results
The endometrial microbial diversity and composition were significantly different between the EP and control groups. Predictive functional analyses of the endometrial microbiota demonstrated significant alterations in pathways involved in sphingolipid metabolism, steroid hormone biosynthesis, and apoptosis between the two groups. Moreover, a classification model based on endometrial microbial ASV-based biomarkers along with the presence of abnormal uterine bleeding symptoms achieved powerful classification potential in identifying EPs in both the discovery and validation cohorts.
Conclusion
Our study indicates a potential association between altered endometrial microbiota and EPs. Endometrial microbiota-based biomarkers may prove valuable for the diagnosis of EPs. Clinical trial registration Chinese Clinical Trial Registry (ChiCTR2100052746).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ambulatory Surgery, Women's Hospital School of Medicine Zhejiang University, Hangzhou, China.
- Zhejiang Provincial Clinical Research Center for Obstetrics and Gynecology, Hangzhou, China.
- Zhejiang Provincial Key Laboratory of Precision Diagnosis and Therapy for Major Gynecological Diseases, Women's Hospital School of Medicine Zhejiang University, Hangzhou, China.
Zitieren
APA
Zhao, Y., Liao, Y., Xu, G., & Wang, Y. (2024). Endometrial microbiota alteration in female patients with endometrial polyps based on 16S rRNA gene sequencing analysis. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2024.1351329
Vancouver
Zhao Y, Liao Y, Xu G, Wang Y. Endometrial microbiota alteration in female patients with endometrial polyps based on 16S rRNA gene sequencing analysis. Frontiers in Cellular and Infection Microbiology. 2024. doi:10.3389/fcimb.2024.1351329
BibTeX
@article{Zhao2024,
author = {Zhao, Yu and Liao, Yun and Xu, Gufeng and Wang, Yue},
title = {Endometrial microbiota alteration in female patients with endometrial polyps based on 16S rRNA gene sequencing analysis},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2024},
doi = {10.3389/fcimb.2024.1351329}
}
EUVIMED